Eliminating the guess work in ablation therapy
Real time predictive visualization of true ablation damage
Real-time ablation.
Visualized.
The world’s first and only image analysis system that predicts and visualizes the 24-hour post-treatment ablation morphology in real-time
Allowing physicians to see where they have previously been blind
BioTrace™ interfaces with commercial ultrasound imaging systems to track the tissue’s unique “biological signature” when responding to heat during thermal ablation. This signature is used to predict and visualize the post 24-hour thermal effect in real-time, optimizing the surgeon’s level of control and accuracy during the procedure, to minimize healthy tissue damage and maximize target tissue ablation.
A comprehensive all-around system
An A to Z Solution, BioTrace™ affects and improves all stages of patient care,
from PSM, through planning & simulation to real-time lesion imaging & efficacy analysis
01. PSM
02. PLANNING
03. MONITORING
04. ANALYSIS
Pre-interventional Patient Specific Modeling
Planning & Validation Of Manufacturers' Protocols
Real-Time Visual Monitoring & Control Of Tissue Destruction
Real-Time Efficacy Analysis Of Post-Treatment Tissue Damage
Providing Vision.
Optimizing Results.
A must have system for optimal ablation
Reduced recurrence rates
Maximize efficacy and
minimize leftover pathologies
Increased safety
Prevent sever injuries
due to overtreatment
Cost effective
No hardware necessary
Quick & easy to adopt
No change to existing
surgical procedures
Case Studies
One real-time image is better than a thousand simulations
CASE 01 Age 61 Procedure RFA Ablation Tumor Size 1.8 cm Liver Segment #3 Ablation time 3 min
92 %
BioTrace™ accuracy compared with 24h post CECT
CASE 02 Age58 ProcedureRFA Ablation Tumor Size2.2 cm Liver Segment#6 Ablation time2.4 min
91 %
BioTrace™ accuracy compared with 24h post CECT
CASE 03 Age63 ProcedureMW Ablation Tumor Size1.5 cm Liver Segment#4 Ablation time2 min
90 %
BioTrace™ accuracy compared with 24h post CECT
Transforming ablation treatments
into guided precision therapies
Current Application
ONCOLOGY
LIVER TUMOR ABLATION
Advancing thermal ablation into the first line
treatment option for tumor removal
Pipeline
CARDIOVASCULAR
Transitioning from complicated guess-work into precise, real-time feedback dependent treatments
PAIN MANAGEMENT
Dramatically increase safety in high-risk nerve-ablation procedures
Team
YOSSI ABU
CEO
YOGEV ZOHAR
R&D Manager
ERAN NAVEH
Software Manager
GAL PERETS
Algorithm Manager
TALIA GOSHEN
Deputy General Manager
ASSAF BASHKIN
Product Manager
SLAVA SHTILERMAN
Software Eng.
DUDI LEVI
DevOps & R&D
INBAL AMITAI
Clinical Engineer
Board
Chairman of the Board
MR. ARIE ROSENFELD
Former President & CEO, Scitex Corp
Director
MR. YOSSI ABU
Founder & CEO,
TechsoMed
Director
MR. EIJI KAKIUCHI
Chairman,
SCREEN Holdings
Director
MR. TAMIR MEIRI
Senior Manager,
JJDC, Inc
Director
MR. FRED SHANE
Managing Partner,
Axil Capital
Director
MR. DAVID HANKIN
CEO,
AMIT-Technion
Partnerships
INVESTORS
PARTNERS
CLINICAL
Contact Us





Contact Info TechsoMed Tel | +972-8-6198866 Email | info@techsomed.com Meir Weisgal 2, Rehovot, Israel